Genmab — Marts 2026

[E_L]

is the same. ' the Company’s holding of treasury shares will be reduced by 1,900,000 shares of a nominal value of DKK 1 each. '

[concillado]

Aaahh.. thx for clarifiation, EL!

[npo]

som i de svenske skove - det der larmer mest er stilheden - var AGM igår en non-event, eller er deltagerne i koma ?

[E_L]

we were all waiting for your contribution

[E_L]

more than twice the day volume in the close. major risk off before the weekend or does it have something to do with today's option expiration

[Raun]

Huhej hvor det går - 1600 står for fald...

[Solsen]

RSI i 27 på adr aktien. Købssignal jf SB

[Raun]

Håber godt nok han får ret denne gang

[E_L]

looks like we may get some data on Rina-s early april -Rinatabart sesutecan (Rina-S) plus bevacizumab (BEV) for patients (pts) with recurrent ovarian cancer (OC): First disclosure from cohort D2 of the phase 1/2 RAINFOL-01 study
Monday, April 13, 2026 via https://sgo2026annualmeeting.eventscribe.net/agenda.asp?BCFO=M|P&pfp=Browse by Day&fa=&fb=&fc=&fd=&all=1

[E_L]

also - Tisotumab vedotin in combination with carboplatin and pembrolizumab with or without bevacizumab in first-line recurrent or metastatic cervical cancer: first disclosure of arm H from the ENGOT-cx8/GOG-3024/innovaTV 205 study

[ProinvestorNEWS]

Genmabs anbefaling sættes op til "køb" hos Baptista https://proinvestor.com/investornyt/1424224/genmabs-anbefaling-saettes-op-til-kob-hos-baptista

[concillado]

Så er vi nede i 1500-regi

[StockBull]

RSI dagkort tæt på de 27 - købt flere i 1592 - GAK under 1800

[Bella1]

Jan van de Winkel valgt som bestyrelsesmedlem i Novo!

[JKY_VH]

Ikke den store overraskelse. Next stop bestyrelsesformand.

[concillado]

Next…. 2027: Breakimg: Genmab fusionerer med Novo

[JKY_VH]

MW" Genmab (+1,3%, 1693,50) har fået indledt dækning med anbefalingen "outperform" og kursmålet 32 dollar af børshuset Wolfe Research. Der går ti amerikanske ADR-aktier på én aktie i København, og dermed svarer kursmålet til 320 dollar - eller omregnet 2075 kr. "

[E_L]

Truist upgraded Genmab to “strong-buy” this week, from its prior Buy stance, according to a March 26 report (Truist had already had Genmab at Buy with a $48 target)

[Solsen]

Spændende udvikling https://finance.yahoo.com/sectors/healthcare/articles/johnson-johnson-darzalex-daratumumab-becomes-103100883.html

[E_L]

Xian Deng

UBS
Buy Kr.2,600.00 Reiterated 26/3 2026